28 results on '"Pozo‐Rosich, Patricia"'
Search Results
2. Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review
3. Migraine worsening after COVID‐19 and COVID‐19 vaccination: Are we facing a nocebo effect?
4. Patterns of response toanti‐CGRPmonoclonal antibodies during first 6‐months of treatment in resistant migraine patients: impact on outcome
5. Virtual issue: COVID ‐19 and headache
6. Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review
7. The relationship of headache as a symptom to COVID ‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID ‐19
8. Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine
9. The influence of temporal unpredictability on the electrophysiological mechanisms of neural entrainment
10. Twenty twenty … two: Headache and COVID‐19
11. Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan
12. Advancing our commitment to our peer reviewers
13. The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org , a headache website in Spanish
14. Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios
15. Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My‐LIFE European Delphi survey
16. Partial and nonresponders to onabotulinumtoxinA can benefit from anti‐CGRP monoclonal antibodies preventive treatment: A real‐world evidence study
17. Headache during COVID‐19: Lessons for all, implications for the International Classification of Headache Disorders
18. Wear‐Off of OnabotulinumtoxinA Effect Over the Treatment Interval in Chronic Migraine: A Retrospective Chart Review With Analysis of Headache Diaries
19. Short and Mid‐Term Predictors of Response to OnabotulinumtoxinA: Real‐Life Experience Observational Study
20. How Does Migraine Change After 10 Years? A Clinical Cohort Follow‐Up Analysis
21. Poster 411 The Impact of OnabotulinumtoxinA on Severe Headache Days: PREEMPT 24‐Week Pooled Analysis
22. SNP variants within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population
23. Voltage‐gated potassium channel antibodies in limbic encephalitis
24. "Code Headache": Development of a protocol for optimizing headache management in the emergency room.
25. The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group.
26. Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
27. European Academy of Neurology guidelines on the treatment of cluster headache.
28. Patterns of response to anti-calcitonin gene-related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.